Huons

휴온스 · 243070

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$240M (₩331.2B)

Overview

Huons makes prescription medicines, including local anaesthetics and eye drops, as well as wellness injectables such as vitamin drips and weight-management drugs.

It supplies hospitals, clinics, and pharmacies across South Korea, and also manufactures medicines on a contract basis for other domestic and international pharmaceutical companies. Listed on KOSDAQ, South Korea's tech and small-cap exchange, the company operates across three distinct segments: prescription pharmaceuticals, beauty and wellness products, and contract manufacturing.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$449.8M

▲ +5.2% YoY

Operating profit · FY2025

US$33M

▲ +14.9% YoY

Net income · FY2025

US$30.6M

▲ +45.3% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$400M(₩552B)	US$427.7M(₩590.2B)	US$449.8M(₩620.8B)
Operating profit	US$40.6M(₩56B)	US$28.8M(₩39.7B)	US$33M(₩45.6B)
Net income	US$36.5M(₩50.4B)	US$21.1M(₩29.1B)	US$30.6M(₩42.2B)

Revenue

FY2023US$400M
FY2024US$427.7M
FY2025US$449.8M

Operating profit

FY2023US$40.6M
FY2024US$28.8M
FY2025US$33M

Net income

FY2023US$36.5M
FY2024US$21.1M
FY2025US$30.6M

Key ratios (FY2025)

ROE

10.2%

Debt/Eq

164.0%

Op. margin

7.3%

Net margin

6.8%

Rev. YoY

▲ +5.2%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?